Trial · NCT07903701
A Phase II/III Clinical Study of SIM0811 in the Treatment of Acute Ischemic Stroke
NCT07903701, Phase 2, Phase 3, Not yet recruiting, Jiangsu Simcere Pharmaceutical Co., Ltd.
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. A Phase II/III Clinical Study of SIM0811 in the Treatment of Acute Ischemic Stroke. Trials, record NCT07903701. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07903701
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- A Phase II/III Clinical Study of SIM0811 in the Treatment of Acute Ischemic Stroke
- NCT number
- NCT07903701
- Status
- Not yet recruiting
- Phases
- Phase 2, Phase 3
- Enrollment
- 1,092 participants, estimated
- Lead sponsor
- Jiangsu Simcere Pharmaceutical Co., Ltd.
- Conditions
- Acute Ischemic Stroke AIS
- Interventions
- SIM0811 Dose Level A (Phase II), SIM0811 Dose Level B (Phase II), SIM0811 Dose Level C (Phase II), Placebo(Phase II), SIM0811（Phase III）, Placebo(Phase III)
- First posted
- 2026-10-29
- Last updated
- 2026-11-06
Source ClinicalTrials.gov
Registered outcomes9
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Proportion of patients achieving a modified Rankin Scale (mRS) score of 0-1 at Day 90 | Day 90 | |
| Secondary | mRS distribution at Day 30 and 90; | Day30 Day 90 | |
| Secondary | Proportions of symptomatic intracranial hemorrhage within 36 h, intracranial hemorrhage, and major extracranial hemorrhage 90-day mortality | Day 0-Day 90 | |
| Secondary | Number of Participants With Any Adverse Event (AE) | Day 0-Day 90 | |
| Secondary | Number of Participants With Treatment-Related Adverse Events (TRAEs) | Day 0-Day 90 | |
| Secondary | Number of Participants With Serious Adverse Events (SAEs) | Day 0-Day 90 | |
| Secondary | Number of Participants With Clinically Significant Abnormal Laboratory Values | Day 0-Day 90 | |
| Secondary | Number of Participants With Clinically Significant Abnormal Vital Signs | Day 0-Day 90 | |
| Secondary | Number of Participants With Clinically Significant Abnormal Physical Examination Findings | Day 0-Day 90 |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07903701
GET https://conductscience.org/api/trials/v1/NCT07903701/registered